Literature DB >> 16432150

The ubiquitin proteolytic system: from a vague idea, through basic mechanisms, and onto human diseases and drug targeting.

Aaron Ciechanover1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432150     DOI: 10.1212/01.wnl.0000192261.02023.b8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  55 in total

Review 1.  Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.

Authors:  Tobias A M Gulder; Bradley S Moore
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-03       Impact factor: 15.336

2.  Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice.

Authors:  Saskia Schlossarek; Friederike Schuermann; Birgit Geertz; Giulia Mearini; Thomas Eschenhagen; Lucie Carrier
Journal:  J Muscle Res Cell Motil       Date:  2011-11-11       Impact factor: 2.698

3.  Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.

Authors:  Cord Naujokat; Carsten Berges; Alexandra Höh; Hubert Wieczorek; Dominik Fuchs; Jörg Ovens; Marion Miltz; Mahmoud Sadeghi; Gerhard Opelz; Volker Daniel
Journal:  Immunology       Date:  2006-11-03       Impact factor: 7.397

4.  Changes in autophagy after traumatic brain injury.

Authors:  Cindy L Liu; Shaoyi Chen; Dalton Dietrich; Bingren R Hu
Journal:  J Cereb Blood Flow Metab       Date:  2007-12-05       Impact factor: 6.200

Review 5.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

Review 6.  Implication of altered proteasome function in alcoholic liver injury.

Authors:  Natalia A Osna; Terrence-M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

7.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

Review 8.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

Review 9.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability.

Authors:  Lauren A Richardson; Benjamin J Reed; J Michael Charette; Emily F Freed; Eric K Fredrickson; Melissa N Locke; Susan J Baserga; Richard G Gardner
Journal:  Cell Rep       Date:  2012-08-16       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.